Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. Training and development programs almost universally focus factory-like on inputs and outputs — absorb curriculum, check a box; learn a skill, advance a rung; submit to assessment, fix a problem.

Development 19

Development Biotechnology CIO Short-term 19

Strategy Driven

MAY 12, 2021

Similarly, the increased development of 3D games, 3D mobile devices, and 3D movies has stimulated the demand for true 3D displays both in consumer and enterprise applications. Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential.

Technology 98

Technology Content Video Globalization 98

Skip Prichard

JULY 22, 2019

Tesla’s genius and education led him to develop the foundations for electric induction motors, wireless telegraphy, radios, neon lamps, and remote control. When Edison developed a commercially viable light bulb, he was able to convince Morgan to advance him $30,000 for the Edison Electric Light Company. Championing change is hard.”

Innovation 80

Innovation Social Capital Reputation How To 80

Harvard Business Review

MAY 7, 2018

But sometimes you need to get into a meeting, perhaps because the decisions made there will have implications for you or your team, or maybe because you feel you’ve been left out of important discussions. Will you or your team be significantly affected by the outcome? You and Your Team Series. Roger Schwarz.

Restructuring 14

Restructuring How To Compliance Biotechnology 14

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Lured by Silicon Valley’s ability to help the company scale up faster, he and his team moved to the Bay Area.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

FEBRUARY 22, 2013

Your company has just developed an amazing new product. Years of development, energy, and, of course, money have gone into it. Having observed management teams for decades as a mutual fund and portfolio manager, I have watched numerous companies vanish after a disastrous launch of a product or service. What do you do next?

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). But how could the team get its Embrace Infant Warmer into the hands of all the hospitals and patients that needed it?

Innovation 9

Innovation Venture Capitalist Company Supply Chain 9

Harvard Business Review

SEPTEMBER 21, 2018

Only 13% of directors in the energy and utilities industry consider innovation to be a major strategic challenge, but the swift growth of renewable energy companies and such developments as the use of drones for monitoring oil and gas production suggest that no industry is impervious to the forces of innovation.

Innovation 12

Innovation Short-term Telecommunications Long-term 12

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. Even individuals on NPS’s leadership team who didn’t embrace our values had to go. To save the 20-year-old company, I had to get it operating like a start-up.

Company 11

Company Pharmaceuticals Biotechnology Short-term 11

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

OCTOBER 22, 2013

Develop Creative Discontent. This industry is fueled by advances in chemistry and biotechnology that allow the use of pharmacological and cosmetic therapies in areas where, earlier, surgical intervention was needed. Once they find it, they work on finding radical ideas and developing business proposals for top executives to review.

Skills 9

Skills Power Six Sigma Disruptive Innovation 9

Harvard Business Review

JUNE 16, 2016

The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. One of the major advantages of this more integrated approach is that product developers can steer discovery-driven researchers in more fruitful directions. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 19, 2015

Clark recommends listing the “concrete skills you need to develop in order to be successful at pursuing your passion full-time.” Seek out training opportunities to help you develop the skills you need for your project. Patch weak spots. ” Once you have a list of necessary skills, figure out how to acquire them.

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

FEBRUARY 3, 2015

By managing the three key properties of networks that either propel you forward or hold you back—breadth, connectivity, and dynamism—you can develop a stronger network and use it as an essential leadership tool. The sidebar “Why We Need Fresh Blood” explains how diversity on any team often produces the best results.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MARCH 30, 2017

Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. Received wisdom is that the more diverse the teams in terms of age, ethnicity, and gender, the more creative and productive they are likely to be. Intuitively, this makes sense.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. The team analyzed their data to understand the outcomes of different patient subtypes and treatment regimens.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. They are founded on new principles and new conceptions, which in turn are painstakingly developed by research in the purest realms of science.” vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JULY 22, 2015

“I have some news,” David Lee told his team member Mark Brown. ” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. I’ll have 25 developers reporting to me.” Andrew Nguyen/HBR STAFF. “Good news?”

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

AUGUST 23, 2016

Republicans generally favor developing a pipeline of diverse candidates through director advocacy and mentorship, while Democrats are more likely to favor requiring that every director slate include diverse candidates, or that boards implement targets for diverse membership. Why does all this matter?

Politics 8

Politics Committee Telecommunications Diversity 8